Report Description

The Argentina over the counter (OTC) drugs market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for common ailments because it gives some health benefits such as cold, flu, and allergies, headache, minor discomfort, and other benefits, as well as the growing need for personalized pharmaceuticals as part of a regular health routine.    The growing demand for lifestyle-related conditions additives, as well as the increasing demand for common ailments, and the convenience and accessibility of OTC drugs, which can be obtained without a prescription at pharmacies and supermarkets, are expected to contribute to the lucrative growth of the Argentina OTC drugs market over the next few years.. According to Statistics Argentina, as of 2022, revenue generated by the Argentina over the counter (OTC) drugs market was USD121.4 through skin treatment and USD90.05 through digestive and intestinal remedies, which caters to the highest count in Argentina.

OTC drugs are also used to manage chronic conditions such as arthritis, diabetes, and high blood pressure. As the population in Argentina ages, the demand for OTC drugs to manage these conditions is expected to grow. OTC drugs are also used to manage lifestyle-related conditions such as insomnia, anxiety, and obesity.

Increasing E-Pharmacy and New Digital Shopper Drives the Market Growth

he growing demand for E-pharmacies and the increasing number of digital shoppers are important drivers of the Argentina over the counter (OTC) drugs market. E-pharmacies give customers a viable option to buy over-the-counter medications online. According to data from the Argentine Chamber of Electronic Commerce (CACE), online sales in Argentina increased by 124% in 2020, compared to the previous year, reaching approximately USD6.6 billion in sales. The growing market for E-commerce is also driving the market for Argentina over the counter (OTC) drugs market. E-pharmacies provide increased accessibility to OTC drugs, particularly for those who live in remote or underserved areas of Argentina. The World Bank collection of development indicators reports that around 7.771% population of Argentina lives in rural areas. This is especially important for elderly or disabled individuals who may have difficulty physically accessing traditional brick-and-mortar pharmacies. E-pharmacies often offer competitive prices, which can help consumers save money on OTC drugs. This is particularly important for individuals who are uninsured or underinsured. Also, they can use data and technology to personalize the shopping experience for individual consumers. This can help consumers find the right OTC drugs to meet their specific needs. Such factors may drive the growth of the Argentina over the counter (OTC) drugs market during the forecast period. 

Inclination Of Companies Toward Over the Counter (OTC) Drugs

OTC drugs are generally more profitable than prescription drugs, as they have lower development costs and can be sold at higher profit margins. This profitability has incentivized many pharmaceutical companies to focus more on developing and marketing OTC drugs. Developing an OTC drug typically requires lower development costs compared to prescription drugs, as OTC drugs often have simpler formulations and do not require extensive clinical trials. The manufacturing cost of OTC drugs in Argentina can vary widely depending on the complexity of the product and the size of the production run. Some estimates suggest that the total manufacturing cost of an OTC drug can range from $2 million to $20 million. OTC drugs often have higher profit margins compared to prescription drugs, as they can be sold at a higher markup due to their accessibility and convenience. As Compared to the sales of prescription pharmaceuticals, the average gross profit margin on nonprescription drugs is from 32% to 36%.

Consumer demand for OTC drugs has been increasing across the world, driven by a desire for convenience, accessibility, and affordability. This has led pharmaceutical companies to shift their focus toward developing OTC drugs to meet this demand. Nearly 9 out of every 10 Latin Americans use OTC medications regularly—that is more than 260 million population prefer OTC medication. Such factors will drive the growth of the Argentina over the counter (OTC) drugs market during the forecast period.

Advertisements And Promotions Promise Market Growth 

Advertising and promotions play a significant role in driving the growth of the Argentina over the counter (OTC) drugs market. This can help increase brand awareness and recognition among customers, making the product more memorable and increasing the likelihood of customers purchasing the product. In 2019, the top 10 OTC drug companies in Argentina spent a total of $68 million on advertisements and promotions, up from $52 million in 2014.

Advertising and promotions can highlight the unique features and benefits of a particular OTC drug product, making it stand out from other similar products in the market. According to a survey conducted by Kantar IBOPE Media, TV is the most effective advertising medium for promoting OTC drugs in Argentina, with 79% of consumers stating that TV ads influence their purchasing decisions. Effective advertising and promotions can help build trust and credibility in the brand, which can lead to increased customer loyalty and repeat purchases. By effectively promoting their products, OTC drug companies can gain a competitive advantage in the market, leading to increased sales and market share as this may help increase brand awareness and drive the growth of the Argentina over the counter (OTC) drugs market.

Growth of Private Label Retail Brands

The growth of private label retail brands is driving the Argentina over the counter (OTC) drugs market. Private label retail brands typically offer OTC drugs at lower prices than branded products, making them more affordable for customers. This can lead to increased sales volume and market share for private label brands. Retail brands allow retailers to have greater control over their product offerings and pricing strategies, which can help them to better meet the needs of their customers and increase sales. Retail brands are becoming increasingly popular among customers in Argentina, with many customers viewing them as a viable alternative to branded products. Argentina is using promotional activities such as price discounts, bundling offers, and loyalty programs to drive sales. In 2019, promotions accounted for 10% of the total sales for OTC drugs in Argentina. This trend is driving the growth of the Argentina over the counter (OTC) drugs market.


Download Free Sample Report

Recent Developments

In 2019, Laboratorios Bagó acquired the Argentine OTC drug company, Ibupirac. This acquisition allowed Laboratorios Bagó to expand its product portfolio in the analgesics and anti-inflammatory categories.

In 2020, Laboratorio Elea Phoenix acquired the Argentine OTC drug company, Prodinvest. This acquisition allowed Laboratorio Elea Phoenix to expand its product portfolio in the dermatology and OTC categories.

In 2021, the Argentine pharmaceutical company, Richmond, announced that it had signed an agreement with the Russian Direct Investment Fund (RDIF) to produce the Sputnik V vaccine in Argentina. This development will not only boost the company's production capabilities but also position it as a major player in the global vaccine market.

Market Segmentation

The Argentina over the counter (OTC) drugs market can be segmented by product type, route of administration, dosage form, distribution channel, and region. Based on product type, the market can be segmented into cough, cold, and flu; vitamins, mineral, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. Based on route of administration, the market can be segmented into oral, topical, and parenteral. Based on dosage form, the market can be segmented into tablets, capsules, liquids & solution, creams/lotions/ointments, and others. Based on distribution channel, the market can be grouped into retail pharmacy, hospital pharmacy, and e-pharmacy.

Market Players

Bayer Argentina S.A., Bristol-Myers Squibb Argentina S.R.L., GlaxoSmithKline Argentina S.A., Laboratorios Bagó S.A., Laboratorios Elea S.A.C.I.F., Laboratorios Roemmers S.A.I.C.F., Laboratorios Sidus S.A., Merck Sharp & Dohme Argentina S.A., Novartis Argentina S.A., and Pfizer Argentina S.R.L./Argentina are some of the leading players operating in the Argentina over the counter (OTC) drugs market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product Type

Route of Administration

Dosage Form

Distribution Channel

Regional scope

Pampas, Litoral, Northwest, Sierras, and Cuyo

Key companies profiled

Bayer Argentina S.A., Bristol-Myers Squibb Argentina S.R.L., GlaxoSmithKline Argentina S.A., Laboratorios Bagó S.A., Laboratorios Elea S.A.C.I.F., Laboratorios Roemmers S.A.I.C.F., Laboratorios Sidus S.A., Merck Sharp & Dohme Argentina S.A., Novartis Argentina S.A., Pfizer Argentina S.R.L./Argentina.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, the Argentina Over the Counter (OTC) Drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Argentina Over the Counter (OTC) Drugs Market, By Product Type:

o      Cough, Cold, and Flu

o      Vitamins, Mineral, and Supplement

o      Analgesics

o      Gastrointestinal Products

o      Dermatology Products

o      Others

  • Argentina Overt the Counter (OTC) Drugs Market, By Route of Administration:

o      Oral

o      Topical

o      Parenteral

  • Argentina Over the Counter (OTC) Drugs Market, By Dosage Form:

o      Tablets

o      Capsules

o      Liquid & Solutions, Creams/Lotions/Ointments

o      Others

  • Argentina Over the Counter (OTC) Drugs Market, By Distribution Channel:

o      Retail Pharmacy

o      Hospital Pharmacy

o      E-Pharmacy

  • Argentina Over the Counter (OTC) Drugs Market, By Region:

o      Pampas

o      Litoral

o      Northwest

o      Sierras

o      Cuyo

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Argentina over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Argentina over the counter (OTC) drugs market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Argentina Over the Counter (OTC) Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product Type (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)

5.2.2.    By Route of Administration (Oral, Topical, Parenteral)

5.2.3.    By Dosage Form (Tablets, Capsules, Liquid & Solutions, Creams/Lotions/Ointments, Others)

5.2.4.    By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.2.5.    By End User (Adults, Geriatric, Pregnant Females, Children, Infants)

5.2.6.    By Region

5.2.7.    By Company (2022)

5.3.  Market Map

6.    Argentina Cough, Cold, Flu Over the Counter (OTC) Drugs Market Outlook

6.1.  Market Size & Forecast        

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Route of Administration

6.2.2.    By Dosage Form

6.2.3.    By Distribution Channel

7.    Argentina Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Outlook

7.1.  Market Size & Forecast        

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Route of Administration

7.2.2.    By Dosage Form

7.2.3.    By Distribution Channel

8.    Argentina Analgesics Over the Counter (OTC) Drugs Market Outlook

8.1.  Market Size & Forecast        

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Route of Administration

8.2.2.    By Dosage Form

8.2.3.    By Distribution Channel

9.    Argentina Gastrointestinal Over the Counter (OTC) Drugs Market Outlook

9.1.  Market Size & Forecast        

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Route of Administration

9.2.2.    By Dosage Form

9.2.3.    By Distribution Channel

10.  Argentina Dermatology Over the Counter (OTC) Drugs Market Outlook

10.1.             Market Size & Forecast         

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Route of Administration

10.2.2. By Dosage Forms

10.2.3. By Distribution Channel

11.  Market Dynamics

11.1.             Drivers

11.2.             Challenges

12.  Market Trends & Developments

12.1.             Merger & Acquisition

12.2.             Product Development

12.3.             Recent Developments

13.  Policy & Regulatory Landscape

14.  Porters Five Forces Analysis

14.1.             Competition in the Industry

14.2.             Potential of New Entrants

14.3.             Power of Suppliers

14.4.             Power of Customers

14.5.             Threat of Substitute Products

15.  Argentina Economic Profile

16.  Competitive Landscape

16.1.             Business Overview

16.2.             Company Snapshot

16.3.             Products & Services

16.4.             Financials (As Reported)

16.5.             Recent Developments

16.5.1. Bayer Argentina S.A.

16.5.2. Bristol-Myers Squibb Argentina S.R.L.

16.5.3. GlaxoSmithKline Argentina S.A.

16.5.4. Laboratorios Bagó S.A.

16.5.5. Laboratorios Elea S.A.C.I.F.

16.5.6. Laboratorios Roemmers S.A.I.C.F.

16.5.7. Laboratorios Sidus S.A.

16.5.8. Merck Sharp & Dohme Argentina S.A.

16.5.9. Novartis Argentina S.A.

16.5.10.               Pfizer Argentina S.R.L./Argentina

17.  Strategic Recommendations

About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The rising growth of e-pharmacy, inclination of companies toward OTC drugs and advertising and promotions are some of the major factors driving the growth of the Argentina over the counter (OTC) drugs market.

down-arrow

Bayer Argentina S.A., Bristol-Myers Squibb Argentina S.R.L., GlaxoSmithKline Argentina S.A., Laboratorios Bagó S.A., Laboratorios Elea S.A.C.I.F., Laboratorios Roemmers S.A.I.C.F., Laboratorios Sidus S.A., Merck Sharp & Dohme Argentina S.A., Novartis Argentina S.A., and Pfizer Argentina S.R.L./Argentina. are some of the leading players operating in the Argentina over the counter (OTC) drugs market.

down-arrow

The retail pharmacy is expected to dominate the Argentina over the counter (OTC) drugs market during the forecast period due to high availability and accessibility of retail pharmacies.

down-arrow

Economic instability, competition from counterfeit products, and consumer education are the major challenges to the Argentina over the counter (OTC) drugs market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Argentine Over the Counter (OTC) Drugs Market to be dominated by Retail Pharmacy through 2028

Aug, 2023

The increasing awareness about over the counter (OTC) drugs is expected to drive the growth of the Argentina over the counter (OTC) drugs market during the forecast period.